Concepedia

Publication | Open Access

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

DOIFull Paper Access

927

Citations

25

References

2016

Year

Toni K. Choueiri, Bernard Escudier, Thomas Powles, Nizar M. Tannir, Paul N. Mainwaring, Brian I. Rini, Hans J. Hammers, Frede Donskov, Bruce J. Roth, Katriina Peltola,
The Lancet Oncology

References

YearCitations

Page 1